Overview

The Effect on Depressive Symptoms in ECF Residents With COPD

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of treatment with Advair Diskus on depression using the Cornell depression scale in COPD patients in the nursing home.
Phase:
Phase 4
Details
Lead Sponsor:
Valley Medical Research
Treatments:
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone-Salmeterol Drug Combination